Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Impact of Sars-Cov-2 Infection in Acute Myeloid Leukemia Patients: Experience of the Pethema Registry

Pilar Martínez, MD, Tomás Palanques Pastor, Jose Luiz Lopez Lorenzo, MD, Javier Cornago Navascués, MD, Gabriela Rodriguez-Macías, MD, Isabel Cano, MD, Montserrat Arnan Sangerman, María-Belén Vidriales, MDPhD, Jesús Lorenzo Algarra, Maria Angeles Foncillas, Pilar Herrera Puente, Carmen Botella, Susana Vives, MD, Angela Figuera Alvarez, MD PhD, Laida Cuevas Palomares, Marta Sobas, MDPhD, Alejandro Contento-Gonzalo, MD, Rebeca Cuello, MD, María Elena Amutio Diez, MD, Maria Dunia De Miguel, MD, Begoña Navas, MD, Juan Miguel Bergua Burgues, MD, Teresa Bernal del Castillo, MD PhD, María Carmen Mateos Rodríguez, MD, Erik de Cabo López, MD, Ana Carolina Franco Villegas, MD, Raimundo García-Boyero, MD, Cristian Escolano Escobar, MD, Cristina Seri, MD, Carlos Cervero, MD, Alicia Roldán Pérez, Maria Lourdes Hermosin, MD, Marta Cervera, MD, María Teresa Olave, MD, Paola Sandra Villafuerte Gutierrez, MD, Almudena De Laiglesia, MD, Josefina Serrano, MD, María Josefa Najera Irazu, MD, Jose Luis Piñana Sanchez, Miguel Ángel Sanz, MD, Joaquin Martinez-Lopez, MD, Pau Montesinos, MD PhD

Blood (2020) 136 (Supplement 1): 7–8.

https://doi.org/10.1182/blood-2020-138471

Published: 2020

Journal Articles

Influence of Cytarabine Metabolic Pathway Polymorphisms in Acute Myeloid Leukemia Induction Treatment

Juan Eduardo Megías-Vericat, PharmD, Montesinos Pau, MD PhD, María José Herrero, PhD, Federico Moscardó, MD PhD, Virginia Bosó, PharmD, David Martínez-Cuadrón, MD PhD, Luis Rojas, MD, Rebeca Rodríguez-Veiga, MD, David Hervás, Blanca Boluda, MD, Luis Sendra, PhD, Jaime Sanz, MD PhD, Antonio Miguel, PhD, Jose Cervera, MD PhD, José Luis Poveda, PhD, Salvador F Aliño, PhD, Miguel Ángel Sanz, MD PhD

Blood (2016) 128 (22): 5130.

https://doi.org/10.1182/blood.V128.22.5130.5130

Published: 2016

Journal Articles

Individualized Prophylactic Treatment with Recombinant Factor VIII in Severe or Moderate Haemophilia a Patients. Association Between Pharmacokinetic Parameters and Clinical Variables

Juan Eduardo Megías-Vericat, PharmD, María Remedios Marqués, PhD, Saturnino Haya, MD, Ana Rosa Cid, MD, Felipe Querol, MD, Emilio Monte, PhD, María García-Dasí, Patricia Caunedo, Carmen Vila, Pau Bosch, Rafael Curats, Miguel Ángel Sanz, MD PhD, José Luis Poveda, PhD, Santiago Bonanad, MD

Blood (2016) 128 (22): 3802.

https://doi.org/10.1182/blood.V128.22.3802.3802

Published: 2016

Journal Articles

Preliminary Results of the Flugaza Trial: A Phase III Randomized, Open Label Study Comparing Azacytidine Versus Fludarabine and Cytarabine (FLUGA Scheme) in Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia

Blood (2016) 128 (22): 4036.

https://doi.org/10.1182/blood.V128.22.4036.4036

Published: 2016

Journal Articles

Comparative Study of Post-Transplant Lymphoproliferative Disorders after Solid Organ Transplantation Versus Hematopoietic Stem Cell Transplantation

Samuel Romero, Sr., Juan Montoro, Sr., Jaime Sanz, MD, Marta Guinot, Sr., Empar Mayordomo, Sr., Rafael López, Sr., Isabel Beneyto, Sr., Luis Almenar, Sr., Amparo Soler, Sr., Guillermo Sanz, MD PhD, Miguel Ángel Sanz, MD PhD

Blood (2015) 126 (23): 4358.

https://doi.org/10.1182/blood.V126.23.4358.4358

Published: 2015

Journal Articles

Impact of Transporter Genes Polymorphisms in Standard Induction of Acute Myeloid Leukemia

Juan Eduardo Megías, PharmD, Pau Montesinos, MD, María José Herrero, PhD, Federico Moscardó, Virginia Bosó, PharmD, David Martínez-Cuadrón, MD, Luis Rojas, MD, Rebeca Rodríguez-Veiga, MD, Blanca Boluda, MD, Jesús Martínez, MD, Jaime Sanz, MD, Francisca López, MD, Isabel Cano, MD, Aima Lancharro, MD, Jose Cervera, MD, David Hervás, José Luis Poveda, PhD, Salvador F Aliño, PhD, Miguel Ángel Sanz, MD PhD

Blood (2015) 126 (23): 4842.

https://doi.org/10.1182/blood.V126.23.4842.4842

Published: 2015

Journal Articles

Influence of Single Nucleotide Polymorphisms in Anthracycline Metabolism Pathway in Standard Induction of Acute Myeloid Leukemia

Blood (2015) 126 (23): 4845.

https://doi.org/10.1182/blood.V126.23.4845.4845

Published: 2015

Journal Articles

Prognostic Impact of Anthracycline Metabolism Gene Polymorphisms in Newly Diagnosed Acute Myeloid Leukemia Adults

Juan Eduardo Megías, PharmD, Pau Montesinos, MD, María José Herrero, PhD, Federico Moscardo, MD, Virginia Bosó, PharmD, David Martínez-Cuadrón, Luis Rojas, Rebeca Rodríguez-Veiga, MD, Blanca Boluda, Jesus Martinez, MD, Jaime Sanz, MD, Francisca López, MD, Isabel Cano, Carmen Alonso, MD, Aima Lacharro, José Cervera, José Luis Poveda, PhD, Salvador Aliño, PhD, Miguel Ángel Sanz, MD PhD

Blood (2014) 124 (21): 2237.

https://doi.org/10.1182/blood.V124.21.2237.2237

Published: 2014

Journal Articles

Novel Assay for Ex Vivo Evaluation of Antiproliferative Effect of Hypomethylating Agents 5-Azacytidine and Decitabine in AML Patient Samples

Pilar Hernandez, PhD, Pau Montesinos, MD, Josefina Serrano, MD, Pilar Herrera, MD, Juan Pedro Bergua, MD, Mercedes Colorado, MD, Bernando J Gonzalez, MD, Cristina Gomez, Alicia Robles, Julian Gorrochategui, Jesus Sanchez, Joan Ballesteros, PhD, Federico Moscardo, MD, David Martinez, MD, Miguel Angel Sanz, MD, Jaime Pérez de Oteyza, MD, Joaquin Martinez, MD

Blood (2014) 124 (21): 5311.

https://doi.org/10.1182/blood.V124.21.5311.5311

Published: 2014

Journal Articles

Prognostic Impact of Cytarabine Pathway Gene Polymorphisms in Acute Myeloid Leukemia Adults Undergoing Induction Chemotherapy

Juan Eduardo Megías, PharmD, Pau Montesinos, MD, Virginia Bosó, PharmD, Federico Moscardo, MD, María José Herrero, PhD, David Martínez-Cuadrón, Rebeca Rodríguez-Veiga, MD, Luis Rojas, Blanca Boluda, Jesus Martinez, MD, Jaime Sanz, MD, Francisca López, MD, Isabel Cano, Carmen Alonso, MD, Aima Lacharro, José Cervera, José Luis Poveda, PhD, Salvador Aliño, PhD, Miguel Ángel Sanz, MD PhD

Blood (2014) 124 (21): 5223.

https://doi.org/10.1182/blood.V124.21.5223.5223

Published: 2014

Journal Articles

Population Pharmacological Profiles Of AML Treatments In Patient Samples By Automated Flow Cytometry; A Bridge To Individualized Medicine

Blood (2013) 122 (21): 1347.

https://doi.org/10.1182/blood.V122.21.1347.1347

Published: 2013

Journal Articles

Prognostic Value of Complex Karyotype and Monosomal Karyotype in Patients with Adult Acute Lymphoblastic Leukemia Treated with Risk-Adapted Protocols

Blood (2012) 120 (21): 4785.

https://doi.org/10.1182/blood.V120.21.4785.4785

Published: 2012

Journal Articles

Aberrant Expression of the MLL5 , BAALC , ID1 , and WT1 Genes Is Associated with Higher Induction Mortality and Poorer Overall Survival in Acute Promyelocytic Leukemia Patients Treated with ATRA and Anthracycline-Based Chemotherapy: An International Consortium On Acute Promyelocytic Leukemia Study

Blood (2012) 120 (21): 1407.

https://doi.org/10.1182/blood.V120.21.1407.1407

Published: 2012

Journal Articles

Impact of Myeloablative and Reduced Intensity Conditioning On Outcomes After Unrelated Cord Blood Transplantation for Adults with Acute Lymphoblastic Leukemia.

Luciana Tucunduva, MD, Annalisa Ruggeri, MD, Guillermo Sanz, MD, PhD, Sabine Furst, MD, Bernard Rio, MD, Gerard Socie, William Arcese, MD, Mauricette Michallet, MD, PhD, Ibrahim Yakoub-Agha, MD, PhD, Jan J Cornelissen, MD, PhD, Miguel Angel Sanz, Pau Montesinos, Duncan Purtill, Eliane Gluckman, MD, PhD, Vanderson Rocha, MD PhD

Blood (2012) 120 (21): 3117.

https://doi.org/10.1182/blood.V120.21.3117.3117

Published: 2012

Journal Articles

Comparison of Short-Term Outcomes Between CSTIBES02 and ALL Ph08 Trials for Young Patients with Philadephia Chromosome-Positive ALL (Ph+ALL) Differing In Imatinib Dose and Amount of Chemotherapy Before Stem Cell Transplantation

Blood (2011) 118 (21): 2582.

https://doi.org/10.1182/blood.V118.21.2582.2582

Published: 2011

Journal Articles

Outcomes In Patients with Multiple Myeloma Following Autologous Stem Cell Transplantation Using Intravenous Busulfan and Melphalan: A Matched Comparison to a Double Autologous Transplant Strategy

Margarita Blanes, MD, Javier De La Rubia, Prof, Dr, PhD, Juan-Jose Lahuerta, MD, José David Gonzalez, MD, Paz Ribas, MD, Carlos Solano, MD, Miguel Angel Sanz, Dr, PhD

Blood (2010) 116 (21): 3560.

https://doi.org/10.1182/blood.V116.21.3560.3560

Published: 2010

Journal Articles

Treatment of Molecular and Clinical Relapse of Acute Promyelocytic Leukemia (APL) with Arsenic Trioxide: Results of the European Registry of Relapsed APL

Eva Lengfelder, MD, PhD, Francesco Lo-Coco, MD, Pau Montesinos, David Grimwade, PhD, Lionel Ades, Bhuvan Kishore, Maria Pagoni, Safaa M. Ramadan, Massimo Breccia, MD, Alexandra Holowiecka, Anne Pradel, Maria Cristina Sauerland, Pierre Fenaux, MD, PhD, Miguel Angel Sanz

Blood (2010) 116 (21): 15.

https://doi.org/10.1182/blood.V116.21.15.15

Published: 2010

Journal Articles

Specific Chemotherapy and Rituximab In HIV-Infected Patients with Burkitt's Leukemia or Lymphoma. Results of a German-Spanish Study and Analysis of Prognostic Factors

Blood (2010) 116 (21): 3944.

https://doi.org/10.1182/blood.V116.21.3944.3944

Published: 2010

Journal Articles

CD34+ Cell Dose Is the Major Cell Dose Determinant of Myeloid Engraftment After Single Umbilical Cord Blood Transplantation (sUCBT) for Adult Patients with High-Risk Hematologic Malignancies

Jaime Sanz, Pau Montesinos, David Martinez, Ignacio Lorenzo, Javier Palau, Luis Larrea, Dolores Planelles, Guillermo Martin, Isidro Jarque, Javier De La Rubia, Federico Moscardo, Jesus Martinez, Miguel Angel Sanz, Guillermo F Sanz, MD, PhD

Blood (2010) 116 (21): 1339.

https://doi.org/10.1182/blood.V116.21.1339.1339

Published: 2010

Journal Articles

Treatment of High-Risk (HR) Philadelphia Chromosome-Negative (Ph-) Adult Acute Lymphoblastic Leukemia (ALL) According to Baseline Risk Factors and Minimal Residual Disease (MRD). Results of the PETHEMA ALL-AR-03 Trial Including the Use of Propensity Score (PS) Method to Reduce Assignment Bias.

Blood (2009) 114 (22): 322.

https://doi.org/10.1182/blood.V114.22.322.322

Published: 2009

NARROW

Impact of Sars-Cov-2 Infection in Acute Myeloid Leukemia Patients: Experience of the Pethema Registry

Influence of Cytarabine Metabolic Pathway Polymorphisms in Acute Myeloid Leukemia Induction Treatment

Individualized Prophylactic Treatment with Recombinant Factor VIII in Severe or Moderate Haemophilia a Patients. Association Between Pharmacokinetic Parameters and Clinical Variables

Preliminary Results of the Flugaza Trial: A Phase III Randomized, Open Label Study Comparing Azacytidine Versus Fludarabine and Cytarabine (FLUGA Scheme) in Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia

Comparative Study of Post-Transplant Lymphoproliferative Disorders after Solid Organ Transplantation Versus Hematopoietic Stem Cell Transplantation

Impact of Transporter Genes Polymorphisms in Standard Induction of Acute Myeloid Leukemia

Influence of Single Nucleotide Polymorphisms in Anthracycline Metabolism Pathway in Standard Induction of Acute Myeloid Leukemia

Prognostic Impact of Anthracycline Metabolism Gene Polymorphisms in Newly Diagnosed Acute Myeloid Leukemia Adults

Novel Assay for Ex Vivo Evaluation of Antiproliferative Effect of Hypomethylating Agents 5-Azacytidine and Decitabine in AML Patient Samples

Prognostic Impact of Cytarabine Pathway Gene Polymorphisms in Acute Myeloid Leukemia Adults Undergoing Induction Chemotherapy

Population Pharmacological Profiles Of AML Treatments In Patient Samples By Automated Flow Cytometry; A Bridge To Individualized Medicine

Prognostic Value of Complex Karyotype and Monosomal Karyotype in Patients with Adult Acute Lymphoblastic Leukemia Treated with Risk-Adapted Protocols

Aberrant Expression of the MLL5 , BAALC , ID1 , and WT1 Genes Is Associated with Higher Induction Mortality and Poorer Overall Survival in Acute Promyelocytic Leukemia Patients Treated with ATRA and Anthracycline-Based Chemotherapy: An International Consortium On Acute Promyelocytic Leukemia Study

Impact of Myeloablative and Reduced Intensity Conditioning On Outcomes After Unrelated Cord Blood Transplantation for Adults with Acute Lymphoblastic Leukemia.

Comparison of Short-Term Outcomes Between CSTIBES02 and ALL Ph08 Trials for Young Patients with Philadephia Chromosome-Positive ALL (Ph+ALL) Differing In Imatinib Dose and Amount of Chemotherapy Before Stem Cell Transplantation

Outcomes In Patients with Multiple Myeloma Following Autologous Stem Cell Transplantation Using Intravenous Busulfan and Melphalan: A Matched Comparison to a Double Autologous Transplant Strategy

Treatment of Molecular and Clinical Relapse of Acute Promyelocytic Leukemia (APL) with Arsenic Trioxide: Results of the European Registry of Relapsed APL

Specific Chemotherapy and Rituximab In HIV-Infected Patients with Burkitt's Leukemia or Lymphoma. Results of a German-Spanish Study and Analysis of Prognostic Factors

CD34+ Cell Dose Is the Major Cell Dose Determinant of Myeloid Engraftment After Single Umbilical Cord Blood Transplantation (sUCBT) for Adult Patients with High-Risk Hematologic Malignancies

Treatment of High-Risk (HR) Philadelphia Chromosome-Negative (Ph-) Adult Acute Lymphoblastic Leukemia (ALL) According to Baseline Risk Factors and Minimal Residual Disease (MRD). Results of the PETHEMA ALL-AR-03 Trial Including the Use of Propensity Score (PS) Method to Reduce Assignment Bias.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only